跳至主要内容
临床试验/IRCT20200701047979N1
IRCT20200701047979N1招募中3 期

Evaluating the Effect of Levetiracetam on Benzodiazepine Withdrawal Syndrome in Comparison with Placebo

Tehran University of Medical Sciences0 个研究点目标入组 39 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 60 years(—)
性别
All

入选标准

  • Patients who had been taking Benzodiazepines for at least three months, and have not discontinued them for more than one month.

排除标准

  • Patients diagnosed with acute and major psychological disorders, schizophrenia, epilepsy, or concurrent neurological disorders, e.g. Multiple Sclerosis
  • Patients with a history of taking Levetiracetam or receiving concurrent Gabapentin or Carbamazepine in the last six months
  • Patients younger than 15 years of age
  • Allergic reactions to Levetiracetam or its excipients
  • Severe adverse drug reactions

研究者

相似试验